Held on 02 June 2014
Dr.Datsons Labs announced that the Board of Directors at its meeting held on 02 June 2014 transacted the following -Issued 72,05,960 equity shares on conversion of FCCBs for total value of USD 7.30 million at conversion rate of Rs 55 per share.
Consequently, the paid up capital of the Company has increased to Rs 49.91 crore comprising of 4,99,16,955 equity shares of Rs 10 each.
Decided to open representative office in USA and Canada for handling sales of herbal patented lozenges.
The Company liability for unsecured loan has reduced to the tune of USD 36.50 million by way of conversion of FCCBs into equity shares of the Company, therefore, the liability of the Company extinguish and improve the debt equity ratio of the Company.
Powered by Capital Market - Live News
